TITLE

Linkage to Care and Treatment for TB and HIV among People Newly Diagnosed with TB or HIV-Associated TB at a Large, Inner City South African Hospital

AUTHOR(S)
De Lima, Yara Voss; Evans, Denise; Page-Shipp, Liesl; Barnard, Antonia; Sanne, Ian; Menezes, Colin N.; Van Rie, Annelies
PUB. DATE
January 2013
SOURCE
PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To assess the outcomes of linkage to TB and HIV care and identify risk factors for poor referral outcomes. Design: Cohort study of TB patients diagnosed at an urban hospital. Methods: Linkage to care was determined by review of clinic files, national death register, and telephone contact, and classified as linked to care, delayed linkage to care (>7 days for TB treatment, >30 days for HIV care), or failed linkage to care. We performed log-binomial regression to identify patient and referral characteristics associated with poor referral outcomes. Results: Among 593 TB patients, 23% failed linkage to TB treatment and 30.3% of the 77.0% who linked to care arrived late. Among 486 (86.9%) HIV-infected TB patients, 38.3% failed linkage to HIV care, and 32% of the 61.7% who linked to care presented late. One in six HIV-infected patients failed linkage to both TB and HIV care. Only 20.2% of HIV-infected patients were referred to a single clinic for integrated care. A referral letter was present in 90.3%, but only 23.7% included HIV status and 18.8% CD4 cell count. Lack of education (RR 1.85) and low CD4 count (CD4≤50 vs. >250cells/mm³ ; RR 1.66) were associated with failed linkage to TB care. Risk factors for failed linkage to HIV care were antiretroviral-naïve status (RR 1.29), and absence of referral letter with HIV or CD4 cell count (RR1.23). Conclusions: Linkage to TB/HIV care should be strengthened by communication of HIV and CD4 results, ART initiation during hospitalization and TB/HIV integration at primary care.
ACCESSION #
85382107

 

Related Articles

  • Pharmacokinetic interactions between antiretrovirals and rifampicin-based tuberculosis treatment. Cohen, Karen // CME: Continuing Medical Education;Oct2011, Vol. 29 Issue 10, p429 

    The article explains the role of pharmacokinetic interactions in antiretroviral treatment (ART) for patients co-infected with HIV and tuberculosis (TB) in South Africa. The pharmacokinetic interaction are being tapped as potential treatment alternatives to Rifampicin, a drug that is applied on...

  • HIV-Tuberculosis Co-infection in Southern India-a record based study. Pattanshetty, Sanjay M.; Kumar, A.; Pandit, V.; Sneha, K.; Darshan, B. B. // Australasian Medical Journal;Oct2010, Vol. 3 Issue 10, p690 

    The article discusses the study conducted at an Anti-retroviral therapy (ART) centre of Udupi district, South India, which analyzes the tuberculosis (TB)-HIV con-infection among patients on ART. It states that combined pulmonary and extrapulmonary form of TB were common in HIV seropositive...

  • Determinants of Antiretroviral Therapy Initiation and Treatment Outcomes for People Living With HIV in Vietnam. Tran, Dam Anh; Shakeshaft, Anthony; Ngo, Anh Duc; Mallitt, Kylie-Ann; Wilson, David; Doran, Christopher; Lei Zhang // HIV Clinical Trials;Jan/Feb2013, Vol. 14 Issue 1, p21 

    Objectives: This study explores patient characteristics that are significantly associated with very late combination antiretroviral therapy (cART) initiation (CD4 count ≤100 cells/mm³) and examines the association between patient characteristics and treatment outcomes, CD4 recovery, and...

  • Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study. von Wyl, Viktor; Klimkait, Thomas; Yerly, Sabine; Nicca, Dunja; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Böni, Jürg; Aubert, Vincent; Günthard, Huldrych F.; Bucher, Heiner C.; Glass, Tracy R. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive patients. Virologic failure with subsequent emergence of resistance reduces future treatment options and long-term clinical success. Methods:Prospective observational cohort study including...

  • CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy. Peeling, Rosanna W.; Sollis, Kimberly A.; Glover, Sarah; Crowe, Suzanne M.; Landay, Alan L.; Cheng, Ben; Barnett, David; Denny, Thomas N.; Spira, Thomas J.; Stevens, Wendy S.; Crowley, Siobhan; Essajee, Shaffiq; Vitoria, Marco; Ford, Nathan // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, particularly in determining eligibility to initiate antiretroviral treatment (ART). A number of technologies exist for CD4 enumeration, with considerable variation in cost, complexity,...

  • Factors Associated with Late Antiretroviral Therapy Initiation among Adults in Mozambique. Lahuerta, Maria; Lima, Josue; Nuwagaba-Biribonwoha, Harriet; Okamura, Mie; Alvim, Maria Fernanda; Fernandes, Rufino; Assan, Americo; Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: Despite recent changes to expand the ART eligibility criteria in sub-Saharan Africa, many patients still initiate ART in the advanced stages of HIV infection, which contributes to increased early mortality rates, poor patient outcomes, and onward transmission. Methods: To evaluate...

  • Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient Study. Buchacz, Kate; Wiegand, Ryan; Armon, Carl; Chmiel, Joan S.; Wood, Kathleen; Brooks, John T.; Palella Jr., Frank J. // HIV Clinical Trials;Aug2015, Vol. 16 Issue 4, p139 

    Objectives: Raltegravir (RAL)-containing antiretroviral therapy (ART) produced better immunologic and virologic responses than optimized background ART in clinical trials of heavily ART-experienced patients, but few data exist on long-term outcomes in routine HIV care. Methods: We studied...

  • Models for Integrating Buprenorphine Therapy into the Primary HIV Care Setting. Basu, Sanjay; Smith-Rohrberg, Duncan; Bruce, R. Douglas; Altice, Frederick L. // Clinical Infectious Diseases;3/1/2006, Vol. 42 Issue 5, p716 

    Opiate dependence among human immunodeficiency virus (HIV)-infected patients has been associated with negative clinical outcomes, yet few affected patients receive appropriate and coordinated treatment for both conditions. The introduction of buprenorphine maintenance therapy into HIV care...

  • The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings. Achieng, Loice; Musangi, Helen; Billingsley, Katherine; Onguit, Sharon; Ombegoh, Edwin; Bryant, LeeAnn; Mwiindi, Jonathan; Smith, Nathaniel; Keiser, Philip // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background:Pill counts are often used to measure adherence to ART, but there is little data on how they affect adherence. We previously showed a bivariate relationship between clinicians counting pills and adherence in patients receiving HIV care in Kenya. We present a secondary analysis of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics